Image

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Exploring new treatments for adults with Type 1 Diabetes.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Overview: This study is looking at how safe and effective two types of extra medicines are for adults with Type 1 Diabetes (T1D) when used along with insulin. These medicines are called GLP-1RA and SGLTi. The study will last for one year.

GLP-1RA and SGLTi are special medicines that help control blood sugar levels in people with diabetes. They work differently than insulin, which is why they are used as "adjunct" therapies, meaning they are added to regular insulin treatment.

Eligibility: To be in this study, you must be an adult (18 years or older) with T1D and already have a prescription for GLP-1RA or SGLTi. You should have been using these medicines for no more than one week. You also need to use a Continuous Glucose Monitor (CGM) and have data from it for at least one month before joining the study. Lastly, you must agree to take part in the study by signing a consent form.

  • The study lasts for one year.
  • You need to use a CGM device for the study duration.
  • Participation requires informed consent.
Print
Study details
    Type 1 Diabetes

NCT07676565

Indiana University

4 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.